| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,542 | 0,550 | 13:24 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Sequana Medical NV: Transparency Notification from Shareholders | 246 | GlobeNewswire (Europe) | Ghent, Belgium, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Transparency Notification from ShareholdersPRESS RELEASEREGULATED INFORMATION
6 January 2026, 6:00 pm CET
Ghent, Belgium - 6 January 2026 -... ► Artikel lesen | |
| 23.12.25 | Sequana Medical NV: Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan | 589 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan
PRESS RELEASE REGULATED INFORMATION / INSIDE INFORMATION23... ► Artikel lesen | |
| 22.12.25 | Sequana Medical NV: NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 489 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 22, 2025 (GLOBE NEWSWIRE) -- NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT... ► Artikel lesen | |
| 18.12.25 | Sequana Medical NV: Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR | 427 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Builds upon existing granted DSR patents in US, Europe, Japan and ChinaStrengthens DSR patent protection based upon extensive clinical and pre-clinical... ► Artikel lesen | |
| 17.12.25 | Sequana Medical NV: Transparency Notification from Shareholders | 270 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Transparency Notification from ShareholdersPRESS RELEASEREGULATED INFORMATION
17 December 2025, 6:00 pm CET
Ghent, Belgium - 17 December 2025... ► Artikel lesen | |
| 11.12.25 | Sequana Medical NV: Sequana Medical Announces U.S. Commercial alfapump Implantations at University of Pennsylvania | 467 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 11, 2025 (GLOBE NEWSWIRE) -- First implantation of two alfapump patients on the same dayContinuing strategy of working with Key Opinion Leaders at top tier centersStrong pipeline... ► Artikel lesen | |
| 05.12.25 | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES | 328 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 05, 2025 (GLOBE NEWSWIRE) --
PRESS RELEASEREGULATED INFORMATION5 December 2025, 6:00 pm CET
Ghent, Belgium, 5 December 2025 - Sequana Medical NV
(Euronext Brussels:... ► Artikel lesen | |
| 24.11.25 | Sequana Medical NV: Transparency Notification from Shareholders | 431 | GlobeNewswire (Europe) | Ghent, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Transparency Notification from Shareholders
Ghent, Belgium - 24 November 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
| SEQUANA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 24.11.25 | Sequana Medical NV: Sequana Medical Announces First U.S. Commercial alfapump Implantation at Mount Sinai Hospital in New York | 589 | GlobeNewswire (Europe) | Ghent, Belgium, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosisFeedback from hepatology... ► Artikel lesen | |
| 20.11.25 | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 317 | GlobeNewswire (Europe) | Ghent - Belgium, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
PRESS RELEASEREGULATED... ► Artikel lesen | |
| 14.11.25 | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES | 388 | GlobeNewswire (Europe) | Ghent Belgium, Nov. 14, 2025 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT
AND NEW NUMBER OF SHARES
PRESS RELEASEREGULATED INFORMATION14 November 2025, 6:00 pm CET
Ghent... ► Artikel lesen | |
| 16.10.25 | Sequana Medical NV: NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 410 | GlobeNewswire (Europe) | Ghent, Oct. 16, 2025 (GLOBE NEWSWIRE) -- NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
Ghent... ► Artikel lesen | |
| 14.10.25 | Sequana Medical NV: Sequana Medical alfapump System Highlighted at SIR EDGE 2025 Conference | 422 | GlobeNewswire (Europe) | , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Ghent, Belgium - 14 October 2025 - Sequana Medical NV (Euronext Brussels: SEQUA (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant... ► Artikel lesen | |
| 13.10.25 | Sequana Medical NV: Transparency Notification from Shareholder | 375 | GlobeNewswire (Europe) | Transparency Notification from Shareholder
Ghent, Belgium - 13 October 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment... ► Artikel lesen | |
| 10.10.25 | Sequana Medical NV: Transparency Notification from Shareholder | 435 | GlobeNewswire (Europe) | Transparency Notification from Shareholder
Ghent, Belgium - 10 October 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment... ► Artikel lesen | |
| 03.10.25 | Sequana Medical NV: Transparency Notification from Shareholder | 427 | GlobeNewswire (Europe) | Transparency Notification from Shareholder
Ghent, Belgium - 3 October 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment of... ► Artikel lesen | |
| 30.09.25 | Sequana Medical NV: Sequana Medical's alfapump System Featured in Presentation at 2025 Portal Intervention Symposium | 477 | GlobeNewswire (Europe) | , Sept. 30, 2025 (GLOBE NEWSWIRE) -- Dr. Rahul Patel of Icahn School of Medicine at Mount Sinai presented "alfapump®: Totally Implantable Peritoneal Drain Pump with Urinary Bladder Drainage"
Ghent... ► Artikel lesen | |
| 26.09.25 | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES | 318 | GlobeNewswire (Europe) | SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT
AND NEW NUMBER OF SHARES
Ghent, Belgium, 26 September 2025 - Sequana Medical NV
(Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
| 25.09.25 | Sequana Medical NV: Sequana Medical announces H1 2025 results and provides business update | 3.854 | GlobeNewswire (Europe) | Sequana Medical announces H1 2025 results and provides business update
alfapump® US commercialisation underway; Strengthened US reimbursement with CMS approval of NTAP "top-up" reimbursement; On... ► Artikel lesen | |
| 15.09.25 | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 333 | GlobeNewswire (Europe) | SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
Ghent, Belgium, 15 September 2025 - Sequana Medical NV
(Euronext... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,470 | +1,02 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 45,950 | -0,78 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,240 | -3,28 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,760 | -0,19 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| UNITEDHEALTH | 292,25 | -0,14 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| DRAEGERWERK | 72,60 | -0,68 % | DRAEGERWERK AG & CO KGAA ST zeigt strukturelle Stärke | ||
| MEDTRONIC | 85,21 | -0,23 % | Medtronic Benefits Are Built for Every Chapter | Employees feel confident in their future, cared for in the present, and supported through life's biggest moments. NORTHAMPTON, MA / ACCESS Newswire / January 5, 2026 / As a global leader in healthcare... ► Artikel lesen | |
| GERRESHEIMER | 27,300 | -1,44 % | Gerresheimer AG: Die Klarheit in der Rechnungslegung verbessert sich, aber die Vertrauenslücke bleibt bestehen. HALTEN. | Gerresheimer (GXI) hat das Kapitel der Bill-and-Hold-Buchhaltung abgeschlossen, indem etwa 28 Millionen EUR an Umsätzen für das Geschäftsjahr 2024 vollständig korrigiert wurden, nachdem eine von der... ► Artikel lesen | |
| THERMO FISHER | 527,70 | -0,11 % | Dividendenbekanntmachungen (15.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2969 EUR AMERICAN HOMES 4 RENT US02665T3068 0,3 USD 0,2555 EUR ARES CAPITAL... ► Artikel lesen | |
| STRATEC | 22,350 | +0,22 % | Aktien Frankfurt: Dax vorweihnachtlich träge | FRANKFURT (dpa-AFX) - Nach den moderaten Gewinnen am Freitag ist der deutsche Aktienmarkt etwas schwächer in die kurze Handelswoche vor Weihnachten gestartet. Das Geschehen ist von einem deutlich geringeren... ► Artikel lesen | |
| ESSILORLUXOTTICA | 272,10 | -0,15 % | UBS stuft EssilorLuxottica auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für EssilorLuxottica auf "Buy" mit einem Kursziel von 352 Euro belassen. Zuzanna Pusz rechnet in einer am Montag vorliegenden... ► Artikel lesen | |
| HIMS & HERS HEALTH | 30,100 | -0,89 % | Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization | ||
| ALCON | 68,32 | -1,58 % | Alcon wird US-Unternehmen Staar Surgical nicht übernehmen | VERNIER (dpa-AFX) - Der Augenheilkunde-Konzern Alcon wird das US-Unternehmen Staar Surgical nicht übernehmen. Die Gegenwehr aus Aktionärskreisen von Staar war letztendlich zu groß. Nach mehrmaligem... ► Artikel lesen | |
| RESMED | 213,00 | +0,24 % | RESMED INC: 144 Report of proposed sale of securities | ||
| HEALWELL AI | 0,521 | -1,51 % | Healwell AI Inc: Healwell AI comments on forward-looking Nov. 3 NR |